Figure S3. Representative pyrograms showing gene methylation patterns in DNA urine samples from a bladder cancer patient. Percentage of methylation is indicated above peaks (gray columns) corresponding to the CpG sites in this region. (PPTX 183Â kb
Eggerâs funnel plot of the publication bias test for CDH13 methylation. (DOCX 21Â kb
Boxplots of CpGs in the top diagnostic model from hypermethylated CpGs. Normal data is from benign-a...
Illustrating the definition of probe sets near a TSS using three different genes (RBBP8, MGMT, and L...
Figure S6. DNA methylation profiles for bladder cancer and control tissue samples for the three-gene...
Figure S4. Sensitivity, negative and positive predictive values of urine cytology, the three-gene me...
Table S2. Percentage of methylation for each CpG dinucleotide in the seven selected genes in control...
Figure S1. Flowchart of the entire study. A total of seven hypermethylated genes, differentially exp...
Figure S5. Flow diagram of participants in the cross-sectional study according a) to the three-gene ...
Table S1. Results of modeling using continuous and binary methylation levels. Table S2. the range of...
Table S3. List of CpG islands included in the biomarker panel. Table S4. List of primers and probes....
Table S1. Correlations. Spearman’s rank correlations for the PMR values of each biomarker, ProCUrE, ...
Background: Current standard methods used to detect and monitor bladder cancer (BC) are invasive or ...
Objective To test DNA methylation profiling in detection of urothelial carcinoma in urine. Study Des...
DNA methylation profiles can be used to define molecular cancer subtypes that may better inform dise...
Table S1. Primer sequences for β-Actin, miR-34b/c, and miR-193b (panel #1). Table S2. Scorpion prime...
Eggerâs funnel plot of the publication bias test for CDH13 methylation. (DOCX 21Â kb
Boxplots of CpGs in the top diagnostic model from hypermethylated CpGs. Normal data is from benign-a...
Illustrating the definition of probe sets near a TSS using three different genes (RBBP8, MGMT, and L...
Figure S6. DNA methylation profiles for bladder cancer and control tissue samples for the three-gene...
Figure S4. Sensitivity, negative and positive predictive values of urine cytology, the three-gene me...
Table S2. Percentage of methylation for each CpG dinucleotide in the seven selected genes in control...
Figure S1. Flowchart of the entire study. A total of seven hypermethylated genes, differentially exp...
Figure S5. Flow diagram of participants in the cross-sectional study according a) to the three-gene ...
Table S1. Results of modeling using continuous and binary methylation levels. Table S2. the range of...
Table S3. List of CpG islands included in the biomarker panel. Table S4. List of primers and probes....
Table S1. Correlations. Spearman’s rank correlations for the PMR values of each biomarker, ProCUrE, ...
Background: Current standard methods used to detect and monitor bladder cancer (BC) are invasive or ...
Objective To test DNA methylation profiling in detection of urothelial carcinoma in urine. Study Des...
DNA methylation profiles can be used to define molecular cancer subtypes that may better inform dise...
Table S1. Primer sequences for β-Actin, miR-34b/c, and miR-193b (panel #1). Table S2. Scorpion prime...
Eggerâs funnel plot of the publication bias test for CDH13 methylation. (DOCX 21Â kb
Boxplots of CpGs in the top diagnostic model from hypermethylated CpGs. Normal data is from benign-a...
Illustrating the definition of probe sets near a TSS using three different genes (RBBP8, MGMT, and L...